(Press-News.org)
Metastasis occurs when cancer cells break away from the original tumor and travel through the bloodstream to form new tumors in other parts of the body. It is the leading cause of cancer-related death. Brain metastasis is particularly severe and affects 10-30% of patients with advanced lung, breast, and melanoma cancers. While therapies exist for established brain tumors, there are limited strategies that directly target the very first cancer “seed cells” that enter and lodge in the brain.
Our brains, however, are equipped with immune cells called microglia that rapidly respond to pathogens and cancer cells by engulfing and digesting them. Yet scientists could not explain why microglia sometimes fail to destroy incoming seed cells because they could not watch this critical interaction in real-time in the living brain.
Now, for the first time in this setting, the exact moment when microglia engulfed seed cells trying to spread to the brain has been captured and visualized. Published in Cancer Research, a journal of the American Association for Cancer Research, the study identifies two proteins that seed cells use to avoid being destroyed by microglia when they first arrive. By genetically removing these proteins, researchers showed that microglia play a key role in eliminating cancer cells during the early stage of their arrival in the brain.
Watching microglia and cancer cells interact in real-time—a first for brain metastasis
An international research team led by Dr. Takahiro Tsuji from the Nagoya University Graduate School of Medicine has studied seed cells that travel from the lung to the brain to understand how they behave when they enter the brain—a critical moment when microglia have a chance to destroy them. This window period lasts about 12 days, so by the time symptoms appear or imaging detects a problem, brain tumors have already formed.
"We recorded the interactions between microglia and cancer cells in live mice using an advanced imaging technique called two-photon microscopy," Dr. Tsuji explained.
"While some microglia actively destroyed tumor cells, others instead supported cancer cell survival and growth. To investigate this difference, we applied a newly developed 'opto-omics' approach, in which only the microglia physically interacting with tumor cells were selectively tagged with light, isolated, and analyzed.”
A way to stop cancer seed cells from outsmarting the brain’s microglia
When cancer cells arrive in the brain, they evade being destroyed by microglia by using "don't eat me" signals from two molecules, CD24 and CD47. When these molecules were removed, microglia digested the seed cells and brain tumors were significantly reduced. Furthermore, CD24 and CD47 were found in 50% of samples of human brain metastasis from lung cancer patients, indicating that the findings from this study have potential clinical relevance.
"Some microglia receive signals that reprogram them to help tumors by building blood vessels and creating a protective environment that shields cancer from immune attack," senior author Professor Hiroaki Wake noted. "Understanding why some microglia destroy cancer while others support it at the very first encounter is key to developing better therapies."
The researchers suggest a treatment strategy that removes CD24 and CD47 with antibodies or other therapies to eliminate cancer seed cells within the early stage when microglia can phagocytose cancer seeds.
“This approach focuses on harnessing our brain's immune system to prevent metastasis at a very early stage, rather than treating tumors after they have already formed,” Dr. Tsuji said.
Looking ahead, the team is developing therapies to remove CD24 and CD47 that could work alone or alongside existing treatments. In parallel, they are creating biomarkers to identify patients most likely to benefit from early intervention. The researchers also plan to extend their imaging technology, which combines two-photon microscopy with opto-omics, to study metastasis in other cancers and organs.
END
UNDER EMBARGO UNTIL 15:00 GMT / 10:00 ET WEDNESDAY 10 DECEMBER 2025
New breakthrough in detecting ‘ghost particles’ from the Sun
First observation of carbon-neutrino interactions opens new frontiers in nuclear and particle physics.
More images available via the link in the Notes Section.
Neutrinos are one of the most mysterious particles in the universe, often called 'ghost particles' because they rarely interact with anything else. Trillions stream through our bodies every second, ...
Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, after a study suggests that one in two individuals arrested and detained in London may have undiagnosed attention-deficit/hyperactivity disorder (ADHD) and one in 20 may have undiagnosed autism.
Research has consistently found that neurodivergent individuals – particularly autistic people and those with ADHD – are overrepresented within prison populations. There is also growing evidence ...
Fukuoka, Japan—Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the explanation often lies in your DNA, or more precisely, your gene types.
People share the same genes but not the exact same gene types. These types are unique combinations of multiple DNA sequence differences that together shape our biological traits. Researchers have long investigated these genetic variations, but traditional tools analyze only 150-300 bases at a time, providing isolated “dots” of information. Advances ...
The African CDC has recently warned of a surge in cholera cases across the continent. Cholera, caused by certain strains of V. cholerae, is a waterborne infection that spreads rapidly, particularly in areas with limited access to clean water and sanitation. Africa bears the majority of the global burden of cholera, accounting for 46% of all cases and nearly 83% of all deaths. Yet, only about 1.3% of laboratories on the continent have the bacteriology capacity to confirm infections.
In 2024, representatives from ...
SAN ANTONIO — December 10, 2025 — Southwest Research Institute (SwRI) and Trinity University will improve a prodrug, a compound activated in the body, to mitigate tissue and organ damage associated with heart attacks, strokes and traumatic injuries. These conditions cause a lack of blood flow, but treatment to reverse blockages can also lead to lasting damage.
A project collaboratively funded by SwRI and Trinity will address both the initial lack of blood (ischemia) and the rush of blood that follows treatment (reperfusion) referred to as ischemia/reperfusion injury (IRI).
“The moment oxygen comes flooding back ...
SAN ANTONIO – The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with the current standard-of-care endocrine therapy in patients with early-stage, hormone receptor (HR)-positive, HER2-negative breast cancer, according to the results of the phase III IidERA trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
“For patients with HR-positive breast cancer—which accounts for about 70% of breast cancer ...
Washington, D.C. December 10, 2025 – Gen Z views the world as a scary place, according to new research presented at the 2025 Society for Risk Analysis Conference. In ongoing research that began in Fall 2022, Gabriel Rubin, Ph.D. a justice studies professor at Montclair State University, has now conducted 104 long-form interviews with Gen Z young people in the Northeast United States about their views on politics, risk and protest—expanding on his initial findings from the study, Gen Z Risk Perceptions: ...
• Measurement accuracy of oxidase biosensors for glucose, lactate, and creatinine increased from about 50 to 99 percent
• Oxygen previously caused inaccuracies; the new method removes oxygen
• Researchers see potential applications ranging from personalized medicine to agriculture
Biosensors are helping people with chronic conditions worldwide live better lives. However, their measurement accuracy has often been relatively low, limiting the range of possible applications. ...
Researchers have harnessed a new statistical technique that allows forest managers to use incomplete satellite imagery for precise forest inventories, bypassing the need for complex and often uncertain data repair processes. The method, known as a "hybrid estimator," is particularly valuable for leveraging decades of archived data from the aging Landsat 7 satellite, which has been collecting images with systematic gaps since 2003.
The study, published in Forest Ecosystems, addresses a critical challenge in forestry and climate science. Remote sensing is vital for large-scale ...
A chemical found in dark chocolate could slow the rate of biological ageing.
Research from King’s College London has found that the chemical theobromine, a common plant compound that comes from cocoa, could have anti-ageing properties.
The study, published today in Aging, compared levels of theobromine in people’s blood, with blood-based markers of biological ageing.
Biological age markers indicate how old your body seems based on its health and function, as opposed to the years you have lived. These markers ...
